Specific Nerve Cell Degeneration Linked to Loss of Smell, Study Reports
Degeneration of a specific class of nerve cells leads to loss of the sense of smell, a symptom often associated…
Articles by Catarina Silva, MSc
Synaptic Proteins Linked to Parkinson’s Could Aid in Early Intervention, Study Says
Key proteins involved in neuron communication are potential targets that could aid in early diagnosis and prediction of disease progression…
Speech Analysis May Help Diagnose Parkinson’s and at Earlier Stage, Study Says
Techniques that analyze speech and vocal patterns might be effective tools to diagnose Parkinson’s disease, and possibly at earlier stages than…
Sunovion’s Below-the-Tongue Therapy Eases Parkinson’s Movement Difficulties, Trial Shows
Sunovion Pharmaceuticals’Â below-the-tongue version of a Parkinson’s therapy was able to ease patients’ movement difficulties after the standard therapy levodopa…
Axovant’s Parkinson’s Therapy Shows Promise but Alzheimer’s Candidate Falls Short, Phase 2 Trials Show
An Axovant Sciences therapy for Parkinson’s disease showed signs of effectiveness, but an Alzheimer’s treatment did not, according to separate Phase…
Changes in Specific Brainstem Nerve Cells Linked to Parkinson’s for First Time
It’s widely accepted that Parkinson’s disease (PD) patients experience neuronal death in the brainstem. Now, for the first time, researchers…
Measuring Caffeine Levels in Blood Might Help Diagnose Early Parkinson’s, Study Suggests
Low levels of blood caffeine and its metabolites may help identify patients with early Parkinson’s disease, according to new…
Tapeworm Treatment May Work to Slow Parkinson’s in Patients with PINK1 Mutations
Niclosamide, an oral medication widely used to eradicate tapeworm infections, may have the potential to slow disease progression in Parkinson’s…
Excess Protein Deposits in Brains of Parkinson’s Patients Don’t Influence Cognition, Study Finds
Researchers at the University of California found that tau and beta-amyloid protein deposits in the brains of Parkinson’s patients does…
FDA OKs Boston Scientific’s Brain Stimulation System for Parkinson’s Patients
The U.S. Food and Drug Administration has approved Boston Scientific’s Vercise Deep Brain Stimulation system to help Parkinson’s patients…